04/07/2025
1:15 PM | Esperion Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SCHEDULE 13G/A | |
04/04/2025
3:15 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
2:20 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
2:23 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
2:11 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
4:15 PM | Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:16 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:16 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:17 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
10:12 AM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/07/2025
8:04 AM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ESPR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/04/2025
6:26 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
2:34 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
2:26 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
1:37 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/21/2025
3:37 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:38 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
2:30 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
2:17 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
7:40 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:12 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:13 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:14 PM | Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
6:10 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
2:46 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
2:21 PM | Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
2:22 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2024
5:43 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:42 AM | Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G/A | |
11/12/2024
1:23 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:22 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:22 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:33 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
11:09 AM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G | |
10/18/2024
3:08 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
3:34 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/17/2024
2:25 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:11 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:12 PM | Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
2:20 PM | Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Elon’s 2025 Silver Crisis (What It Means for You) (Ad) Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. With Elon Musk leading the charge, supplies are vanishing fast. Don't wait until it's out of reach. Claim your FREE 2025 Silver Wealth Guide today and take control of your financial future. |
09/17/2024
2:28 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:33 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/12/2024
3:08 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:21 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
7:29 AM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
7:30 AM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
2:22 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
2:11 PM | Esperion Therapeutics (Subject)
Foody Joanne M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
7:03 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
3:16 PM | Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:20 PM | Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
2:09 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
2:19 PM | Esperion Therapeutics (Subject)
Foody Joanne M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
3:26 PM | Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
05/28/2024
3:16 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
2:08 PM | Esperion Therapeutics (Subject)
Warren Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
7:50 AM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:29 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:21 PM | Esperion Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:19 PM | Esperion Therapeutics (Filer)
| Form ARS | |
